Drug Database
Back to search

Belgium· BE-AMP-SAM294341-00

Imodium Duo 2 mg - 125 mg

A loperamid, kombinationen product containing simeticone, registered in Belgium by Kenvue Belgium. The same ATC class is registered in 9 of our 19 countries.

ATC A07DA53

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedImodium Duo 2 mg - 125 mgATCA07DA53REGISTER NO.BE-AMP-SAM294341-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about simeticoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Loperamid, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC A07DA53 (loperamid, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search loperamid, kombinationen products by name

Loperamid, kombinationen · ATC A07DA53

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Simeticone
Manufacturer
Kenvue Belgium
Country
Belgium (BE)
ATC code
A07DA53
ATC class
Loperamid, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2797389

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07DA53

Loperamid, kombinationen, as other registers publish it.

All loperamid, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/508244eb-46e4-4b06-a987-46918b2a588c
GET /v1/drugs/508244eb-46e4-4b06-a987-46918b2a588c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Imodium Duo 2 mg - 125 mg",
  "name_fr": "Imodium Duo 2 mg - 125 mg",
  "name_nl": "Imodium Duo 2 mg - 125 mg",
  "amp_code": "SAM294341-00",
  "strengths": [
    "133.0000",
    "133.0000",
    "125.0000",
    "125.0000",
    "2.0000",
    "2.0000",
    "125.0000",
    "25.0000",
    "25.0000",
    "4.4000"
  ],
  "pack_count": 16,
  "substances": [
    "Simeticone",
    "Dimeticone",
    "Loperamide Hydrochloride",
    "Sodium Starch Glycolate (Type A)",
    "Acesulfame Potassium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Loperamide, Combinations",
  "authorisation_numbers": [
    "BE294341",
    "BE294366"
  ]
}
API referenceMCP serverPlans

See everything about loperamid, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console